Recently, Komen issued a statement saying that Myriad had sued it in four consecutive intellectual property lawsuits. What's funny is that being sued is a dishonorable thing, and people usually hate to cover it up, but Coleman did the right thing and issued a statement of its own to tell the world about it. When Myriad sued Rippon, it was a press conference with a lot of fanfare, and at the juncture of Rippon's listing, it was enough to piss him off. Why didn't Myriad hold a press conference when they sued Corman? Is Komen a small company or a small lawsuit is not newsworthy, or Komen is not listed and does not need to mobilize the power of the media to attack, or is it that Myriad itself feels that it is dishonorable to use a lawsuit to bully a weaker counterpart?
Lebanon and Myriad's major shareholders are Anke out of the same teacher brothers, companies have always had business dealings, the volume of sales and purchases is also considerable, a few bosses often go to Dongguan entertainment. Zhang Hao did not dream that the night before the listing of Xu Hang and Li Xiting will put him to death. According to Myriad insiders say, Xu Hang is to do technical origin, not very good at the whole person, but Li Xiting was the director of the Office of the Security Branch, he is a good hand at the whole person. There is a story that two employees in the construction of Myriad received a favor fee, Li Xiting told executives to do their ideological work, as long as the money to hand over to write a review will not be blamed. The executives to complete the work, to Li Xiting that turned over the difference, I thought, this time two subordinates will miss him this love, die to follow him, did not expect Li Xiting turned around to take the review to the public security, and immediately arrested the person. Rumors are not enough to test, but Li Xiting, the short, big-eyed Shanghai man in the medical equipment industry is a formidable, as the Shenzhen Medical Equipment Industry Association, no one in the industry dare to mess with. This time, he was again a big fight against Coman, it seems that Coman is moving his cake.
In the 1990s, China's medical device manufacturing industry is a blank slate, the monitor is the largest consumption of medical equipment, who can copycat the monitor, who will be able to get rich. At that time in the Anke holding a golden bowl of young people saw the opportunity, they left the golden bowl out of the company, Myriad, JinkoWei, Ribon, Paulette and other companies came into being, their bosses are from the Anke, and they are all the production of monitors, and they are all earning the first bucket of gold. 2000 years later, to do the competition for monitors is big, the difference between the companies gradually highlights the difference between the Myriad rely on the introduction of venture capital to increase investment in human and material resources, to make a difference in the non-monitory industry, the company is the most competitive in the world. The investment of human and material resources, in the SARS, other rivals production and inventory is not enough, he seized the opportunity to rise. To date, Myeri's monitors still account for more than 30% of the company's sales. Since its listing in the U.S., Myeri has been making money more and more easily, and the major shareholders have been focusing on stocks and real estate, circling the globe in the name of R&D centers, and acquiring small companies everywhere with stock market money. The headache for Myriad is that the money is more, but his main business is not advancing but retreating, after deducting the financial results brought by his acquisition of the company, his monitor business is actually declining. Xu Hang looked at the non-competitive monitor product line, simply resigned to play real estate to go, I do not know that the two fires in Shenzhen Bay No. 1 can save his mind.
Here's a little paragraph. Li Xiting is really in charge, look at a few old colleagues old rivals of the monitor. JinKeWei defected to Philips, also, the home of the product copy is Philips, and Philips is still solid global boss, don't go to mess with; Ribbon, last time a few lawsuits hit him has not breathed; BaoLite little brother, it seems that now there is no intention to play guardianship, go to the whole thing of that hemodialysis to go. Corman, Corman this rash young, was not established for a few years sales even ranked the second domestic position. Coman is not Anke out, only do a guardianship, by what these two years of development so fast, called the marketing department to study the study. Market research found that the development of Coman is too fierce, product development is too fast, not only in dealing with Myri's traditional guardianship aspects, a lot of products, but also a whole bunch of specialized special monitors, to beat him, only the same production of specialized monitors. No, follow Komen, can not afford to lose face. I'd like to ask the Legal Department to think of a way, this is a good idea, Myriad has more money, Coman has less money, with him to fight the lawsuit, the first trade secrets, the whole big point, and then a large number of patent cases, burn money to burn him to death.
Corman moved the Myriad monitor this piece of cake. In Myriad's view, Komen is not moving a small piece of cake, but wants to grab a whole piece of cake of the monitor.
Myers from the ordinary monitor to plug-in monitor to half-plug-in monitor, spent more than 20 years, it is difficult to save the whole monitoring product line, Coman a few years all out, and the quality is also better. An online evaluation article, Coman NC12 compared to the latest IPM12 monitor, Coman won. Other domestic counterparts in the monitor, always lower than the Myriad head, small brand, poor quality, low price. Coman surprisingly challenge the quality and price of Myeri, Coman a brand competition dragged into the product competition in the theory, let Myeri shudder.
Komen's bigger killer app is his specialized monitors, he a C60 neonatal special monitors, out of the rapid capture of the market, in the neonatal unit, even Philips and Dr?ger's monitors were Komen squeezed out, not to mention the Myriad. Myri has never played in the domestic monitor rivals in front of the price war, while talking about the brand while the big price cuts, or can not save him in the neonatal section of the losing trend. A neonatology is not enough, Coman came out a C100 cardiovascular monitor, this product even GE, Philips are inferior to themselves, which is the monitor, it is simply a combination of electrocardiogram machine and the monitor of the freak, the function is super invincible.
The most frightening thing is not that the opponent is physically strong, the most frightening thing is that the opponent has a mind. It's like the ****productivist ideology of the ****productivist party, those so-called Western democracies who are not afraid of him. Coleman put forward "specialized is the development trend of the monitor" product ideas, hit the key point of Myriad. Ideological competition is not a piece of cake competition is not a city and a pool of gains and losses, is to move the root of the life, that is the battle between you and I live and die. Coleman boss Yi Yong a speech - "Welcome to Myriad also do specialized monitors", I do not know how Li Xiting interpretation, he will not read into the welcome speech, he felt more Coleman to him under the letter of war, right. Myeri will not sit back and wait for death, in order to maintain the king of his traditional monitors, he also want to theoretically refute, Myeri marketing department successive articles "IPM series monitoring more suitable for neonatology" and "IPM series monitoring more suitable for cardiovascular". These are two counter-attacking weapons, was instead treated by Coleman as grabbed the tail of the Myeri, to "welcome Myeri to join the team of specialty-specific" flirted with.
What's scary about Komen is not only his products and his product ideas, but their sales model is equally scary. The two companies are not doing direct sales only distribution, the difference is that Myri only focus on agents and distributors, will run the hospital equipment section chief and the dean and other purchasing decision makers relationship, Myri held the big agents, Coman in the already inextricably linked with Myri in front of the big agents, not to be seen, their salesman will specialize in the hospital department to run for doctors and nurses to explain the product and provide a trial machine, Coman created the first medical equipment sales in China, the first to provide a trial machine, the first to provide a trial machine, the first to provide a trial machine, the first to provide a trial machine, the first to provide a trial machine, the first to provide a trial machine. Coman created the first medical equipment sales in China, the first manufacturer to provide free prototypes for hospitals to try. Myriad emphasizes on customers and Coman emphasizes on users. Myriad has a high reputation among the upper level customers and Coman has a high reputation among the lower level users. Coman is not the same sales model is also from another aspect of the Myriad cake.
No matter which piece of cake Coman is moving the Myri, the two domestic monitor of the boss and the oldest two war has been playing up, Myri put the fire from the market competition dragged to the court to see each other, I do not know whether Coman can carry, I do not know the monitor this is not for the people of the industry can not get out of the people specializing in "specialties" of the innovative road! I don't know whether the monitor industry, which is not well known to the general public, can come out of the "specialty-specific" innovation.